Literature DB >> 24520238

Kerion, report of a missed case.

Farhang Babamahmoodi1, Abdolreza Babamahmoodi2, Lotfollah Davoodi1.   

Abstract

Entities:  

Year:  2013        PMID: 24520238      PMCID: PMC3906779     

Source DB:  PubMed          Journal:  J Res Med Sci        ISSN: 1735-1995            Impact factor:   1.852


× No keyword cloud information.
Sir, In recent years due to improvements in the health status of the population, the incidence of some diseases is reduced and medical practitioners and medical students rarely meet such cases Therefore, in practice, the patients may be misdiagnosed and don’t receive proper treatment and almost the wrong or late management may cause irreversible sequels. We faced with an 11-year-old boy in Razi's Hospital (Qa’em Shahr City-North of Iran) [Figure 1] who he had a primary presenting scaly and pruritic plaque on his scalp since 2 weeks before that progressively changed to an ulcerated crusted, exudative, and painful erythematous plaque with palpable indurations. Otherwise, he was quite healthy without any underlying immunity disorder. The patient had contact with soil. He had received oral antibiotics (full dose of cephalexin and cloxacillin), without any improvement, our impression was kerion. In direct smear with KOH and endothrix hyphae within hair shaft was seen but because of surface contamination and saprophytes growth in culture laboratory could not report type of fungous. He was treated with oral terbinafine 125 mg/day for 4 weeks and completely cured [Figure 2]. Not any other drugs such as corticosteroid, antibiotics or anti histamines used. Kerion is a hypersensitivity reaction due to dermatophyte infection of the scalp (scalp ring worm) that characterized by an exudative painful mass lesion. Etiology of disease is a zoophilic fungi that species varies from geographic region.[1] Boys less than 15 years old are more susceptible for this disease and in older age it is seen mostly in immune diffident patients.[23] It may induce the scaring alopecia if untreated.
Figure 1

Before treatment

Figures 2

After treatment

Before treatment After treatment Although recently in modern world, kerion is infrequently seen, tinea capitis as a world-wide health problem needs careful clinical consideration, evaluation, and regional epidemiologic studies.[12] Tinea capitis kerion in any scalp lesion with crusted and infected lesions with lymphadenopathy are in the differential diagnosis list and physician should be suspicious to this disease and with clinical and mycological diagnosis treatment begin to prevent scarring alopecia.[2] Although griseofulvin is drug of choice, but Terbinafine because of shorter course of treatment and lesser side-effects than griseofulvin and fluconazole is better recommended.[456] Neglected infectious diseases need more attention. Inadvertency and incuriosity to these types of disease may cause some irreversible problems for patients.
  4 in total

1.  Guidelines for the management of tinea capitis. British Association of Dermatologists.

Authors:  E M Higgins; L C Fuller; C H Smith
Journal:  Br J Dermatol       Date:  2000-07       Impact factor: 9.302

2.  Comparative evaluation of griseofulvin, terbinafine and fluconazole in the treatment of tinea capitis.

Authors:  Chander Grover; Pooja Arora; Vikas Manchanda
Journal:  Int J Dermatol       Date:  2012-04       Impact factor: 2.736

3.  Epidemiology of dermatophytoses: retrospective analysis from 2005 to 2010 and comparison with previous data from 1975.

Authors:  Gino A Vena; Paolo Chieco; Filomena Posa; Annarita Garofalo; Anna Bosco; Nicoletta Cassano
Journal:  New Microbiol       Date:  2012-03-31       Impact factor: 2.479

4.  Guidelines for the management of tinea capitis in children.

Authors:  Talia Kakourou; Umit Uksal
Journal:  Pediatr Dermatol       Date:  2010 May-Jun       Impact factor: 1.588

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.